TNF-a inducing protein (Tipa) is secreted from Helicobacter pylori (H. pylori): it is a potent inducer of TNF-a and chemokine genes, mediated through NF-jB activation, and it also induces tumorpromoting activity in Bhas 42 cells. To investigate the carcinogenic mechanisms of H. pylori with Tipa, we first examined how Tipa acts on gastric epithelial cells. We found that fluorescent-Tipa specifically bound to, and then entered, the cells in a dose-and temperature-dependent manner, whereas deletion mutant of Tipa (del-Tipa), an inactive form, neither bound to nor entered the cells, suggesting the presence of a specific binding molecule. Mutagenesis analysis of Tipa revealed that a dimer formation of Tipa with a disulfide bond is required for both specific binding and induction of TNF-a gene expression. A confocal laser scanning microscope revealed some Tipa in the nuclei, but del-Tipa was not present, which indicated that an active form of Tipa can penetrate the nucleus and may be involved in the induction of TNF-a gene expression. Examination of Tipa production and secretion in 28 clinical isolates revealed that H. pylori obtained from gastric cancer patients secreted Tipa in significantly higher amounts than did H. pylori from patients with chronic gastritis, suggesting that Tipa is an essential factor in H. pylori inflammation and cancer microenvironment in the human stomach. Tipa is thus a new carcinogenic factor of H. pylori that can enter the nucleus through a specific binding molecule, and its mechanism of action is completely different from that of CagA.